Comparison of daclatasvir resistance barriers on NS5A from hepatitis C virus genotypes 1 to 6: implications for cross-genotype activity

Wang C, Jia L, O'Boyle DR, Sun JH, Rigat K, Valera L, et al. Comparison of daclatasvir resistance barriers on NS5A from hepatitis C virus genotypes 1 to 6: implications for cross-genotype activity. Antimicrob Agents Chemother. 2014;58(9):5155-5163.

Publication Type:

Journal Article

Authors:

Wang, C.; Jia, L.; O'Boyle, D.R.; Sun, J.H.; Rigat, K.; Valera, L.; Nower, P.; Huang, X.; Kienzle, B.; S K Roberts; Gao, M.; Fridell, R.A.

Source:

Antimicrob Agents Chemother, Volume 58, Issue 9, p.5155-5163 (2014)

Keywords:

Amino Acid Substitution, Cell Line, Connecticut, Genomics, Genotype, HCV, hepatitis, Hepatitis C, hepatitis C virus, In Vitro, New Jersey, protease inhibitor, Replicon, Research, Research Support, resistance, Rna, therapy, virology

Notes:

PMC4135806

Cited On:

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/24936600

Export Citation:
RIS Format
Top